- Home
- FBNC vs SRPT Comparison
FBNC vs SRPT Comparison
Compare FBNC & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBNC
- SRPT
- Stock Information
- Founded
- FBNC 1934
- SRPT 1980
- Country
- FBNC United States
- SRPT United States
- Employees
- FBNC N/A
- SRPT N/A
- Industry
- FBNC Major Banks
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- FBNC Finance
- SRPT Health Care
- Exchange
- FBNC Nasdaq
- SRPT Nasdaq
- Market Cap
- FBNC 2.1B
- SRPT 2.0B
- IPO Year
- FBNC N/A
- SRPT 1997
- Fundamental
- Price
- FBNC $53.09
- SRPT $17.06
- Analyst Decision
- FBNC Buy
- SRPT Hold
- Analyst Count
- FBNC 4
- SRPT 31
- Target Price
- FBNC $56.67
- SRPT $40.61
- AVG Volume (30 Days)
- FBNC 206.3K
- SRPT 7.8M
- Earning Date
- FBNC 10-22-2025
- SRPT 11-05-2025
- Dividend Yield
- FBNC 1.74%
- SRPT N/A
- EPS Growth
- FBNC N/A
- SRPT N/A
- EPS
- FBNC 2.35
- SRPT N/A
- Revenue
- FBNC $361,053,000.00
- SRPT $2,481,531,000.00
- Revenue This Year
- FBNC $36.30
- SRPT $10.78
- Revenue Next Year
- FBNC $8.19
- SRPT N/A
- P/E Ratio
- FBNC $22.55
- SRPT N/A
- Revenue Growth
- FBNC N/A
- SRPT 64.89
- 52 Week Low
- FBNC $34.50
- SRPT $10.42
- 52 Week High
- FBNC $56.45
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- FBNC 48.35
- SRPT 42.77
- Support Level
- FBNC $52.64
- SRPT $16.85
- Resistance Level
- FBNC $55.52
- SRPT $18.84
- Average True Range (ATR)
- FBNC 1.14
- SRPT 0.99
- MACD
- FBNC -0.44
- SRPT -0.10
- Stochastic Oscillator
- FBNC 11.81
- SRPT 7.55
About FBNC First Bancorp
First Bancorp is a bank holding company. The company is engaged in providing commercial and consumer banking services, mortgage lending, SBA lending, accounts receivable financing and investment advisory services.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.